Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:BOPH NASDAQ:CARM OTCMKTS:GLGLF OTCMKTS:OPTI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBOPHBohai Pharmaceuticals Group$0.00$0.00$0.00▼$0.00$20K1.7830,425 shs50,000 shsCARMCarisma Therapeutics$0.00+100.0%$0.02$0.00▼$1.27$8K1.0392,692 shs3,489 shsGLGLFGLG Life Tech$0.00$0.00▼$0.00$20K2.1N/AN/AOPTIOptec International$0.00$0.00$0.00▼$0.00$5KN/A1.72 million shs12,439 shsThe 10 Best AI Stocks to Own in 2026Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBOPHBohai Pharmaceuticals Group0.00%0.00%0.00%0.00%0.00%CARMCarisma Therapeutics-66.67%-75.00%-99.68%-99.75%-99.95%GLGLFGLG Life Tech0.00%0.00%0.00%0.00%-95.54%OPTIOptec International0.00%0.00%-42.86%-20.00%-81.82%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBOPHBohai Pharmaceuticals Group$0.00$0.00$0.00▼$0.00$20K1.7830,425 shs50,000 shsCARMCarisma Therapeutics$0.00+100.0%$0.02$0.00▼$1.27$8K1.0392,692 shs3,489 shsGLGLFGLG Life Tech$0.00$0.00▼$0.00$20K2.1N/AN/AOPTIOptec International$0.00$0.00$0.00▼$0.00$5KN/A1.72 million shs12,439 shsThe 10 Best AI Stocks to Own in 2026Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBOPHBohai Pharmaceuticals Group0.00%0.00%0.00%0.00%0.00%CARMCarisma Therapeutics-66.67%-75.00%-99.68%-99.75%-99.95%GLGLFGLG Life Tech0.00%0.00%0.00%0.00%-95.54%OPTIOptec International0.00%0.00%-42.86%-20.00%-81.82%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBOPHBohai Pharmaceuticals Group 0.00N/AN/AN/ACARMCarisma Therapeutics 2.67Moderate Buy$1.00499,900.00% UpsideGLGLFGLG Life Tech 0.00N/AN/AN/AOPTIOptec International 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBOPHBohai Pharmaceuticals GroupN/AN/AN/AN/AN/AN/ACARMCarisma Therapeutics$10.77M0.00N/AN/A($0.67) per share0.00GLGLFGLG Life Tech$7.35M0.00N/AN/A($2.00) per share0.00OPTIOptec InternationalN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBOPHBohai Pharmaceuticals GroupN/AN/AN/AN/AN/AN/AN/AN/AN/ACARMCarisma Therapeutics-$60.48M$0.730.00N/AN/A-254.28%N/A-192.17%N/AGLGLFGLG Life Tech$8.60M$0.22N/AN/AN/A120.13%N/A-261.73%N/AOPTIOptec InternationalN/AN/AN/AN/AN/AN/AN/AN/AN/ALatest OPTI, CARM, BOPH, and GLGLF EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2026Q4 2025GLGLFGLG Life TechN/A-$0.43N/A-$0.72N/A$1.50 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBOPHBohai Pharmaceuticals GroupN/AN/AN/AN/AN/ACARMCarisma TherapeuticsN/AN/AN/AN/AN/AGLGLFGLG Life TechN/AN/AN/AN/AN/AOPTIOptec InternationalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBOPHBohai Pharmaceuticals GroupN/AN/AN/ACARMCarisma TherapeuticsN/A0.480.48GLGLFGLG Life TechN/A0.040.03OPTIOptec InternationalN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBOPHBohai Pharmaceuticals GroupN/ACARMCarisma Therapeutics44.27%GLGLFGLG Life TechN/AOPTIOptec InternationalN/AInsider OwnershipCompanyInsider OwnershipBOPHBohai Pharmaceuticals GroupN/ACARMCarisma Therapeutics6.90%GLGLFGLG Life TechN/AOPTIOptec International50.34%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBOPHBohai Pharmaceuticals GroupN/A19.52 millionN/ANot OptionableCARMCarisma Therapeutics2041.85 million38.91 millionNo DataGLGLFGLG Life Tech1238.39 millionN/ANot OptionableOPTIOptec International111.65 millionN/ANot OptionableOPTI, CARM, BOPH, and GLGLF HeadlinesRecent News About These CompaniesOptec International, Inc. (OPTI) - Yahoo FinanceJuly 13, 2025 | finance.yahoo.comOptec International Inc.May 23, 2025 | barrons.comOptec Technology Ltd.April 29, 2025 | optics.orgONew Optec CEO Updates ShareholdersJanuary 16, 2025 | globenewswire.comNew Optec CEO Updates ShareholdersJanuary 16, 2025 | prismmediawire.comPGlobal Optical Current Transformer Market Size Forecasted to Surpass USD 353.0 Million Valuation by 2033, Surging at 8.4% CAGRNovember 14, 2024 | fmiblog.comFSITC International Expands Fleet with New Vessel OrdersOctober 30, 2024 | markets.businessinsider.comAston University researcher develops new optical technique that could revolutionise medical diagnosticsOctober 25, 2024 | eurekalert.orgEbit.bio Wins Landmark Patent Defence for Groundbreaking opti-ox™ Cell Programming TechnologyOctober 16, 2024 | standard-journal.comSOptical illusion psychology test: What you see first reveals if you are optimist or too cautious in lifeOctober 4, 2024 | timesofindia.indiatimes.comOpti Digital Welcomes Guillem Fiter as Chief Marketing OfficerSeptember 17, 2024 | exchangewire.comEOGP exhibiting exciting lineup of metrology systems at IMTS 2024September 5, 2024 | insights.globalspec.comIAndersen Global Enters Japan with the Collaborating Firm OptiAugust 30, 2024 | tmcnet.comThe Optical Women’s Association Announces Global Connection Event at Silmo ParisAugust 29, 2024 | invisionmag.comIOptical Communication and Networking Equipment Market to Reach $54.0 Billion, Globally, by 2032 at 8.7% CAGR: Allied Market ResearchAugust 20, 2024 | tmcnet.comEngineers bring efficient optical neural networks into focusAugust 14, 2024 | sciencedaily.comSOptical navigation tech could streamline planetary explorationAugust 7, 2024 | msn.comIso-propagation vortices: optical multiplexing for unprecedented information capacityMay 17, 2024 | eurekalert.orgEIDTechEx Release New Global Optical & Radio Frequency Metamaterials Market ReportMay 13, 2024 | tmcnet.comGlobal Optical Coherence Tomography IndustryMay 6, 2024 | fmiblog.comFNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesCorning Beats Q1 Estimates but Drops 9% on Guidance MissBy Ryan Hasson | April 29, 202695% Options Surge: Smart Money Bets Big on a Super Micro Bounce By Jeffrey Neal Johnson | April 15, 2026Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong MomentumBy Chris Markoch | May 10, 2026The New Nokia: A Bullish Upgrade Ignites This Big AI Bet By Jeffrey Neal Johnson | April 16, 2026Why Smart Money Is Quietly Piling Into This Lithium StockBy Jeffrey Neal Johnson | April 29, 2026OPTI, CARM, BOPH, and GLGLF Company DescriptionsBohai Pharmaceuticals Group OTCMKTS:BOPH$0.0010 0.00 (0.00%) As of 03/11/2019Bohai Pharmaceuticals Group, Inc. engages in the production, manufacture, and distribution of herbal pharmaceuticals based on traditional Chinese medicine. Its products include lung nourishing syrup, tongbi capsules, tongbi tablets, zhuangyuanshenhailong medicinal wine, bazhenyimu cream, fangfengtongsheng granule, and zhengxintai capsules. The company was founded on January 9, 2008 and is headquartered in Yantai, China.Carisma Therapeutics NASDAQ:CARM$0.0002 +0.00 (+100.00%) As of 11:25 AM EasternCarisma Therapeutics, Inc., a clinical-stage cell therapy company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases in the United States. The company's ex vivo CAR-M cell therapies include CT-0508, a CAR-macrophage, which is in Phase 1 clinical trial to treat solid tumors; CT-0525, a CAR-monocyte that is in Phase 1 clinical trial to treat solid tumors; and CT-1119, a mesothelin-targeted CAR-Monocyte that is in pre-clinical stage to treat patients with advanced mesothelin-positive solid tumors, including lung cancer, mesothelioma, pancreatic cancer, ovarian cancer, and others. It is also developing in vivo CAR-M cell therapies in collaboration with Moderna Therapeutics to address multiple cancer targets; and multiple assets for the potential treatment of diseases beyond oncology, including fibrosis and other immunologic and inflammatory diseases. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. The company was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.GLG Life Tech OTCMKTS:GLGLFGLG Life Tech Corporation researches for, develops, grows, refines, and produces natural sweeteners extracted from the stevia plant and monk fruit in Canada and internationally. It also offers P-Pro Plus, a pea protein product; REB M GOLD, a bioconverted Rebaudioside M and Rebaudioside D. sweetener; and natural ingredients. It serves in the food and beverage industry. The company was formerly known as GLG Life Tech Limited and changed its name to GLG Life Tech Corporation in March 2007. GLG Life Tech Corporation was incorporated in 1998 and is headquartered in Richmond, Canada.Optec International OTCMKTS:OPTI$0.0004 0.00 (0.00%) As of 10:24 AM EasternOptec International, Inc. engages in selling and marketing optimized fuel maximizer units in North America and internationally. It markets optimized fuel maximizer for passenger vehicles, intermediate/medium duty trucks, off-road equipment, generator systems, heavy duty diesel on-road vehicles, and transportation refrigeration units. The company was formerly known as Green Meadow Products, Inc. and changed its name to Optec International, Inc. in August 2017. Optec International, Inc. was founded in 2012 and is based in Carlsbad, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Dividend Growth or High Yield: The Income Investor's Bet Nebius Upside Expands as AI Feedback Loop Intensifies Oklo Stock Could Be Ready for Another Massive Run Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell Qualcomm Stock Doubles: New Era? Or Another False Start? D-Wave Earnings Looked Weak, But Investors May Be Missing This A Quantum Shift: Why Speculative Money Is Ditching AI A New Focus for GoPro: Is a Takeover in the Frame? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
